Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Association between 5q23.2-located polymorphism of CTXN3 gene (Cortexin 3) and schizophrenia in European-Caucasian males; implications for the aetiology of schizophrenia

O. Šerý, J. Lochman, J. Povová, V. Janout, J. Plesník, VJ. Balcar,

. 2015 ; 11 (-) : 10. [pub] 20150317

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT14504 MZ0 CEP Register

BACKGROUND: The objective of the study was to examine several polymorphisms in DISC1 and CTNX3 genes as possible risk factors in schizophrenia. DISC1 (disrupted-in-schizophrenia 1) has been studied extensively in relation to mental disease while CTXN3, has only recently emerged as a potential "candidate" gene in schizophrenia. CTXN3 resides in a genomic region (5q21-34) known to be associated with schizophrenia and encodes a protein cortexin 3 which is highly enriched in brain. METHODS: We used ethnically homogeneous samples of 175 male patients and 184 male control subjects. All patients were interviewed by two similarly qualified psychiatrists. Controls were interviewed by one of the authors (O.S.). Genotyping was performed, following amplification by polymerase chain reaction (PCR), using fragment analysis in a standard commercial setting (Applied Biosystems, USA). RESULTS: We have found a statistically significant association between rs6595788 polymorphism of CTXN3 gene and the risk of schizophrenia; the presence of AG genotype increased the risk 1.5-fold. Polymorphisms in DISC1 gene showed only marginally statistically significant association with schizophrenia (rs17817356) or no association whatsoever (rs821597 and rs980989) while two polymorphisms (rs9661837 and rs3737597) were found to be only slightly polymorphic in the samples. CONCLUSION: Evidence available in the literature suggests that altered expression of cortexin 3, either alone, or in parallel with changes in DISC1, could subtly perturb GABAergic neurotransmission and/or metabolism of amyloid precursor protein (APP) in developing brain, thus potentially exposing the affected individual to an increased risk of schizophrenia later in life.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010310
003      
CZ-PrNML
005      
20190903103940.0
007      
ta
008      
160408s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12993-015-0057-9 $2 doi
024    7_
$a 10.1186/s12993-015-0057-9 $2 doi
035    __
$a (PubMed)25889058
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šerý, Omar, $u Laboratory of Neurobiology and Molecular Psychiatry, Laboratory of Molecular Physiology, Department of Biochemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37, Brno, Czech Republic. omarsery@sci.muni.cz. Institute of Animal Physiology and Genetics, Academy of Sciences, Veveří 97, 602 00, Brno, Czech Republic. omarsery@sci.muni.cz. $d 1972- $7 xx0060835
245    10
$a Association between 5q23.2-located polymorphism of CTXN3 gene (Cortexin 3) and schizophrenia in European-Caucasian males; implications for the aetiology of schizophrenia / $c O. Šerý, J. Lochman, J. Povová, V. Janout, J. Plesník, VJ. Balcar,
520    9_
$a BACKGROUND: The objective of the study was to examine several polymorphisms in DISC1 and CTNX3 genes as possible risk factors in schizophrenia. DISC1 (disrupted-in-schizophrenia 1) has been studied extensively in relation to mental disease while CTXN3, has only recently emerged as a potential "candidate" gene in schizophrenia. CTXN3 resides in a genomic region (5q21-34) known to be associated with schizophrenia and encodes a protein cortexin 3 which is highly enriched in brain. METHODS: We used ethnically homogeneous samples of 175 male patients and 184 male control subjects. All patients were interviewed by two similarly qualified psychiatrists. Controls were interviewed by one of the authors (O.S.). Genotyping was performed, following amplification by polymerase chain reaction (PCR), using fragment analysis in a standard commercial setting (Applied Biosystems, USA). RESULTS: We have found a statistically significant association between rs6595788 polymorphism of CTXN3 gene and the risk of schizophrenia; the presence of AG genotype increased the risk 1.5-fold. Polymorphisms in DISC1 gene showed only marginally statistically significant association with schizophrenia (rs17817356) or no association whatsoever (rs821597 and rs980989) while two polymorphisms (rs9661837 and rs3737597) were found to be only slightly polymorphic in the samples. CONCLUSION: Evidence available in the literature suggests that altered expression of cortexin 3, either alone, or in parallel with changes in DISC1, could subtly perturb GABAergic neurotransmission and/or metabolism of amyloid precursor protein (APP) in developing brain, thus potentially exposing the affected individual to an increased risk of schizophrenia later in life.
650    _2
$a dospělí $7 D000328
650    _2
$a alely $7 D000483
650    _2
$a DNA $x genetika $7 D004247
650    _2
$a běloši $x genetika $7 D044465
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x genetika $7 D008565
650    _2
$a lidé středního věku $7 D008875
650    _2
$a proteiny nervové tkáně $x genetika $7 D009419
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a schizofrenie $x etiologie $x genetika $7 D012559
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lochman, Jan $u Laboratory of Neurobiology and Molecular Psychiatry, Laboratory of Molecular Physiology, Department of Biochemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37, Brno, Czech Republic. 13418@mail.muni.cz.
700    1_
$a Povová, Jana $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Jana.Povova@osu.cz. $7 xx0172732
700    1_
$a Janout, Vladimír $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Vladimir.Janout@osu.cz.
700    1_
$a Plesník, Jiří $u Laboratory of Neurobiology and Molecular Psychiatry, Laboratory of Molecular Physiology, Department of Biochemistry, Faculty of Science, Masaryk University, Kotlářská 2, 611 37, Brno, Czech Republic. 324081@mail.muni.cz.
700    1_
$a Balcar, Vladimir J. $u Laboratory of Neurochemistry, Bosch Institute and Discipline of Anatomy and Histology, School of Medical Sciences, Sydney Medical School, The University of Sydney, 2006, Sydney, NSW, AUSTRALIA. vibar@anatomy.usyd.edu.au. $7 xx0193457
773    0_
$w MED00163303 $t Behavioral and brain functions BBF $x 1744-9081 $g Roč. 11, č. - (2015), s. 10
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25889058 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20190903104309 $b ABA008
999    __
$a ok $b bmc $g 1113739 $s 934678
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 11 $c - $d 10 $e 20150317 $i 1744-9081 $m Behavioral and brain functions $n Behav Brain Funct $x MED00163303
GRA    __
$a NT14504 $p MZ0
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...